文献速递静脉血栓栓塞

超声辅助导管定向溶栓与机械取栓治疗中危肺栓塞的短期结局

Short-term outcomes of ultrasound-assisted catheter-directed thrombolysis and mechanical thrombectomy in management of intermediate-risk pulmonary embolism.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-03-20

本研究回顾性比较中危肺栓塞患者接受超声辅助导管定向溶栓(USAT)或机械取栓(MT)的短期结局。共纳入120例,USAT组100例,MT组20例。两组ICU住院时间、总住院时间及30天和1年生存率无显著差异,但MT组输血率更高,CTA术前高估RV/LV比值。

要点

  • USAT与MT在中危肺栓塞中短期生存和右心功能改善相似。
  • MT组输血率显著高于USAT组,出血风险患者需谨慎。
  • 术前CTA评估RV/LV比值高于超声心动图,需注意模态差异。

核心结论

  • USAT和MT在中危肺栓塞中提供相似的短期和中期结局,包括生存率、右心功能改善及住院时间。
  • MT与更高的输血率相关,对出血风险患者应谨慎。
  • 支持在多学科肺栓塞响应框架内基于解剖和风险个体化选择导管治疗。

研究设计与样本

  • 单中心回顾性研究,纳入2018至2023年中危肺栓塞患者120例,其中USAT组100例,MT组20例。
  • 中危定义:收缩压>90 mmHg且超声心动图RV/LV比值>0.9。
  • 主要结局为ICU住院时间、医院住院时间及30天和1年生存率。

主要发现

  • 30天生存率分别为98%和100%,1年生存率分别为96%和90%,无显著差异。

临床怎么用

  • 对于中危肺栓塞,USAT和MT均可作为导管治疗选项,选择应基于血栓位置和溶栓禁忌。
  • 对出血风险较高的患者,优先考虑USAT而非MT以减少输血风险。
  • 术前评估RV/LV比值时,需注意CTA可能高估,超声心动图可作为补充。

局限性

  • 单中心回顾性研究,样本量有限(尤其MT组仅20例),可能存在选择偏倚。
  • 原文未报告其他次要结局的具体数值,无法进一步比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to compare preoperative right ventricle-to-left ventricle (RV/LV) ratios by computed tomography angiography (CTA) and echocardiography and evaluate treatment outcomes of ultrasound-assisted catheter-directed thrombolysis (USAT) or mechanical thrombectomy (MT) in patients with intermediate-risk pulmonary embolism (PE). METHODS: We retrospectively identified patients treated for intermediate-risk PE from 2018 to 2023 defined by systolic blood pressure (BP) >90 mmHg and right ventricle dysfunction defined by RV/LV ratio >0.9 via echocardiogram. RV/LV ratios were also evaluated on diagnostic CTA for comparison to echocardiogram values. Patients underwent USAT or MT based on thrombus location and contraindications to thrombolysis. Primary outcomes were intensive care unit (ICU) length of stay (LOS), hospital LOS, and 30-day and 1-year survival. Secondary outcomes included RV/LV change post-treatment on echocardiography, concomitant deep vein thrombosis (DVT), elevated cardiac biomarkers, blood transfusion, history of DVT/PE or malignancy, and imaging modality comparison in determination of RV/LV and RV/LV changes. RESULTS: Of 120 patients from a single center treated for intermediate-risk PE, 100 underwent USAT and 20 MT. There was no difference in ICU LOS (2.4 vs 2.6 days; P = .67) or hospital LOS (4.8 vs 5.7 days; P = .41) for USAT and MT, respectively. There was no difference in 30-day (98% vs 100%), or 1-year survival (96% vs 90%). MT patients had greater incidence of blood transfusion (25% vs 5%; P = .011). CTA overestimated RV/LV ratios preoperatively compared with echocardiography (1.4; SD, 0.4 vs 1.3; SD, 0.2; P = .027). Patients undergoing MT were more likely to have identified lower extremity DVT compared with patients undergoing USAT (90% vs 65%; P = .033). Other secondary outcomes showed no significant differences between treatment groups. CONCLUSIONS: Both USAT and MT provide excellent short-term and intermediate outcomes in patients with intermediate-risk PE, similar survival rates, similar post-treatment change in right heart dysfunction, and comparable ICU and hospital stays. MT is associated with higher transfusion rates, so caution should be exercised in patients felt to be at risk from further blood loss. These findings support individualized, anatomy- and risk-based selection of catheter-based therapy within a multidisciplinary PE response framework.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Horton CE, Wi MS, Sayegh M, et al. Short-term outcomes of ultrasound-assisted catheter-directed thrombolysis and mechanical thrombectomy in management of intermediate-risk pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41866114. doi:10.1016/j.jvsv.2026.102489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。